Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
2,806
-7.94%
|
$106,628
$38.85 P/Share
|
|
Feb 10
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Grant, award, or other acquisition
|
Direct |
7,197
+16.93%
|
-
|
|
Feb 10
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,901
-1.0%
|
$72,238
$38.85 P/Share
|
|
Feb 10
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
6,477
+3.31%
|
-
|
|
Feb 10
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,057
-6.03%
|
$40,166
$38.85 P/Share
|
|
Feb 10
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Grant, award, or other acquisition
|
Direct |
3,598
+17.03%
|
-
|
|
Feb 10
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,193
-3.64%
|
$121,334
$38.85 P/Share
|
|
Feb 10
2021
|
Edward F Mackey EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,796
+10.95%
|
-
|
|
Feb 10
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,924
-1.52%
|
$1,213,112
$38.85 P/Share
|
|
Feb 10
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
71,981
+3.32%
|
-
|
|
Feb 10
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,268
-4.11%
|
$48,184
$38.85 P/Share
|
|
Feb 10
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,318
+12.27%
|
-
|
|
Feb 10
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
2,423
-1.74%
|
$92,074
$38.85 P/Share
|
|
Feb 10
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Grant, award, or other acquisition
|
Direct |
7,917
+5.37%
|
-
|
|
Feb 10
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
2,240
-0.93%
|
$85,120
$38.85 P/Share
|
|
Feb 10
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Grant, award, or other acquisition
|
Direct |
6,477
+2.61%
|
-
|
|
Feb 10
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
3,193
-24.84%
|
$121,334
$38.85 P/Share
|
|
Feb 10
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Grant, award, or other acquisition
|
Direct |
10,796
+45.65%
|
-
|
|
Feb 10
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,432
-3.01%
|
$54,416
$38.85 P/Share
|
|
Feb 10
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,678
+8.96%
|
-
|
|
Feb 10
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,268
-4.49%
|
$48,184
$38.85 P/Share
|
|
Feb 10
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,318
+13.26%
|
-
|
|
Feb 10
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,898
-3.75%
|
$148,124
$38.85 P/Share
|
|
Feb 10
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Grant, award, or other acquisition
|
Direct |
7,197
+6.47%
|
-
|
|
Feb 10
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
8,881
-3.56%
|
$337,478
$38.85 P/Share
|
|
Feb 10
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Grant, award, or other acquisition
|
Direct |
17,995
+6.72%
|
-
|
|
Feb 08
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Bona fide gift
|
Indirect |
1,520
+20.11%
|
-
|
|
Feb 08
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
3,040
-1.3%
|
-
|
|
Feb 08
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
16,902
-37.54%
|
$659,178
$39.39 P/Share
|
|
Feb 08
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+16.66%
|
$117,000
$13.08 P/Share
|
|
Feb 04
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
11,317
-84.62%
|
$430,046
$38.0 P/Share
|
|
Feb 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
919
-3.34%
|
$32,165
$35.95 P/Share
|
|
Feb 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,130
+10.23%
|
-
|
|
Jan 05
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
17,083
-6.09%
|
$597,905
$35.32 P/Share
|
|
Jan 05
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
8,108
-5.8%
|
$283,780
$35.31 P/Share
|
|
Jan 04
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-5.89%
|
$25,200
$36.08 P/Share
|
|
Jan 01
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,396
-2.57%
|
$258,860
$35.95 P/Share
|
|
Jan 01
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,479
+7.84%
|
-
|
|
Jan 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
4,758
-11.67%
|
$166,530
$35.95 P/Share
|
|
Jan 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,879
+21.06%
|
-
|
|
Jan 01
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
3,085
-1.66%
|
$107,975
$35.95 P/Share
|
|
Jan 01
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
9,791
+5.0%
|
-
|
|
Jan 01
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,809
-11.49%
|
$63,315
$35.95 P/Share
|
|
Jan 01
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,439
+25.68%
|
-
|
|
Jan 01
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
13,619
-5.49%
|
$476,665
$35.95 P/Share
|
|
Jan 01
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
27,199
+9.87%
|
-
|
|
Jan 01
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,001
-6.1%
|
$175,035
$35.95 P/Share
|
|
Jan 01
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,318
+16.59%
|
-
|
|
Jan 01
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
44,291
-2.14%
|
$1,550,185
$35.95 P/Share
|
|
Jan 01
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
108,797
+5.0%
|
-
|